Healthcare
HeraMED Limited (ASX:HMD)
Industry Group : Health Care Equipment & Services | Industry Group Name : Health Care Equipment & Supplies
Market Price : AUD 0.210.005 (2.439%)
(as on 2021-09-26 09:00:35)
| Previous Close | Open | Close* | Day Range | 52 WEEK HIGH LOW |
|---|---|---|---|---|
| 0.205 | 0.21 | 0.21 | 0.21L 0.22 H | 0.086L 0.305 H |
| Last Trade | 0.21 |
|---|---|
| Change% | 2.4390 |
| 52 W H/L | 0.305/0.086 |
| EBITDA | -3.501 M |
|---|---|
| NPAT After Abnormal Items | -4.361 M |
| Equity | 2.594 M |
| ROE% | -168.10% |
| Total Liabilities | 1.553 M |
|---|---|
| Total Revenue | 166,765 |
| Cash and Cash Equivalents | 2.472 M |
Stock Information
| Share price | 0.21 |
|---|---|
| Market Cap | 37.21 M |
| Price/Gross Cash Flow | -6.07 |
| Dividend Yield Excluding Special | 0.00% |
| Ending Shares | 150.039 M | 52-Week Range | 0.086-0.305 |
| P/E ratio | 0.000 |
|---|---|
| Sector P/E | -- | EPS | -3.51 |
| EV/EBITDA | -- |
| Net Profit Margin (%) | -8,500.28% |
| Gross Cash Flows Per Share | -0.02 |
| Net Gearing | -85.69% |
| Gross DPS (AUD) | 0 |
|---|---|
| Gross Dividend Yield (Annualized) | 0.00% |
| Earnings Yield | 0.000 |
| Net Tangible Asset (NTA) | 0.01 |
| Sales Per Share | 0.00 |
| Book Value Per Share | 0.02 |
Announcements
About Company
HeraMED is an Israeli company founded in 2011. Its flagship product is HeraBEAT, smartphone-based, efficient fetal heartbeat monitoring system for expectant mothers. As on 12th December, the company successfully completed its IPO of $6 million (NIS 15.8 million) at A$0.20 per share and subsequently listed on ASX.
Corporate Information
|
|
|
|
Suite 3, 23-25 Hunter Street, SYDNEY, NSW, AUSTRALIA, 2000
+61 2 8379 2961
Dividends
| Ex-Dividend Date | Franking | DPS (AUD) | Dividend Yield |
|---|---|---|---|
| 30/12/2020 | -- | 0.000 | 0.00% |
| 30/12/2019 | -- | 0.000 | 0.00% |
| 30/12/2018 | -- | 0.000 | 0.00% |
Event Calendar
| Event Type | Event Date | Event Year |
|---|---|---|
| Report (Interim) | 2022-08-26 | 2022 |
| Report (Annual) | 2022-03-28 | 2022 |
| Report (Prelim) | 2022-02-25 | 2022 |
Financials
| Breakdown | 30/12/2020 | 30/12/2019 | 30/12/2018 |
|---|---|---|---|
| Trading Revenue | 51,306 | 207,520 | 109,335 |
| Other Revenue | 115,459 | 98,873 | 0 |
| Total Revenue | 166,765 | 306,394 | 109,335 |
| Interest Income | 17,451 | 55,097 | 0 |
| Interest Expenses | -13,405 | -10,633 | -1.263 M |
| Expenses | -4.196 M | -4.47 M | -3.887 M |
| EBITDA | -4.029 M | -4.164 M | -3.778 M |
| Depreciation and Amortization | -335,853 | -346,694 | -295,161 |
| Depreciation | -6,608 | -7,396 | -9,589 |
| Amortisation | -329,244 | -339,297 | -285,572 |
| EBIT | -4.365 M | -4.51 M | -4.073 M |
| Pre Tax Profit | -4.361 M | -4.466 M | -5.336 M |
| Tax Expense | 0 | 0 | 0 |
| Net Profit After Tax | -4.361 M | -4.466 M | -5.336 M |
| Minority Interest | 0 | 0 | 0 |
| Preference Dividend | 0 | 0 | 0 |
| Net Abnormal Items | 0 | 0 | 0 |
| Reported Net Profit After Abnormal Items | -4.361 M | -4.466 M | -5.336 M |
| Ending Shares | 150.039 M | 103.213 M | 87.529 M |
| Weighted Average Shares | 125.768 M | 88.512 M | 36.972 M |
| EPS After Abnormal Items (cents) | -3.47 | -5.05 | -14.43 |
| Breakdown | 30/12/2020 | 30/12/2019 | 30/12/2018 |
|---|---|---|---|
| Total Current Assets | 2.865 M | 3.366 M | 6.116 M |
| Total Non Current Assets | 1.282 M | 1.778 M | 1.712 M |
| Total Assets | 4.147 M | 5.144 M | 7.828 M |
| Total Current Liabilities | 669,837 | 769,790 | 708,968 |
| Total Non Current Liabilities | 883,064 | 965,949 | 969,941 |
| Total Liabilities | 1.553 M | 1.736 M | 1.679 M |
| Net Assets | 2.594 M | 3.408 M | 6.149 M |
| Breakdown | 30/12/2020 | 30/12/2019 | 30/12/2018 |
|---|---|---|---|
| Net Operating Cash | -3.608 M | -3.892 M | -2.502 M |
| Net Invested Cash | -87,396 | -295,782 | -246,062 |
| Net Financing Cash Flows | 3.267 M | 1.176 M | 8.451 M |
| End Cash Position | 2.472 M | 2.92 M | 5.715 M |
| Beginning Cash | 2.656 M | 5.758 M | 64,613 |
| Exchange Rate Adjustments | 244,851 | 174,160 | -51,581 |
| Other Cash Adjustments | 0 | 0 | 0 |
| Ending Cash | 2.472 M | 2.92 M | 5.715 M |
© 2021 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice or ‘regulated financial advice’ under New Zealand law has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. For more information refer to our Financial Services Guide (AU) and Financial Advice Provider Disclosure Statement (NZ) at www.morningstar.com.au/s/fsg.pdf and www.morningstar.com.au/s/fapds.pdf. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Our publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Some material is copyright and published under license from ASX Operations Pty Ltd ACN 004 523 782.